Quantamental Technologies’s ChemoCentryx, Inc. CCXI Stock Holding History

Quantamental Technologies’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,182	Closed	-$376K	–	703
2022 Q2	$376K	Buy	+15,182	New	+$335K	0.17%	227
2022 Q1	–	Sell	-19,962	Closed	-$727K	–	590
2021 Q4	$727K	Buy	+19,962	New	+$701K	0.37%	84
2019 Q3	–	Sell	-4,906	Closed	-$46K	–	1914
2019 Q2	$46K	Buy	+4,906	New	+$56.8K	0.02%	926

Other funds holding CCXI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Quantamental Technologies's CCXI Position: Q3 2022 in Review

Quantamental Technologies sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 15,182 shares — an estimated $376K sold.

Quantamental Technologies first reported a position in CCXI in Q2 2019 and held it in 3 quarters. The position peaked at $727K in Q4 2021. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

Quantamental Technologies reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
Quantamental Technologies sold 15,182 ChemoCentryx, Inc. shares in Q3 2022, an estimated $376K.
Quantamental Technologies first reported a position in ChemoCentryx, Inc. in Q2 2019 and held it in 3 quarters.
Quantamental Technologies's ChemoCentryx, Inc. position peaked at $727K in Q4 2021.
217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on Quantamental Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.